Bioversys Ag
Clinical trials sponsored by Bioversys Ag, explained in plain language.
-
New drug combo targets deadly brain TB in landmark trial
Disease control Not yet recruitingThis study tests a new two-drug combination (Alpibectir and Ethionamide) added to standard treatment for tuberculosis meningitis, a serious brain infection. Researchers will measure how well the drugs reach the brain and their safety in 64 newly diagnosed patients. The trial also…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated May 26, 2026 11:56 UTC
-
New hope against superbugs: experimental drug combo targets deadly hospital infections
Disease control Not yet recruitingThis study tests a new drug called BV100 combined with other antibiotics to treat serious hospital-acquired infections like pneumonia and bloodstream infections caused by a hard-to-treat bacteria (CRABC). About 120 adults will take part to see if the combo is safe and works bette…
Phase: PHASE2 • Sponsor: BioVersys AG • Aim: Disease control
Last updated May 26, 2026 11:54 UTC